Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Burkholderia Cepacia Complex Causing Pneumonia in an Immunocompetent Non-Cystic Fibrosis Patient: Case Report and Review of Literature

Author(s): Priya Datta, Menal Gupta*, Mani B. Kumar, Varsha Gupta and Jagdish Chander

Volume 20, Issue 1, 2020

Page: [106 - 110] Pages: 5

DOI: 10.2174/1871526518666181022112857

Price: $65

Abstract

Background: Burkholderia cepacia complex is widespread in the environment and has been recognized as a cause of opportunistic pulmonary infections, particularly in patients with Cystic Fibrosis (CF). The natural ecology of the bacteria as part of plant growth-promoting rhizosphere provides stark contrast to its infectious potential. Its preponderance as a nosocomial pathogen may be due to its ability to survive in antiseptic solutions, contaminate equipments and intrinsic antimicrobial resistance.

Case: An elderly, diabetic male was evaluated for hemoptysis, fever and cough. Chest computed tomography showed a thick walled cavity in the left lung and hilar lymphadenopathy. Sputum examination showed Gram negative bacilli and no acid fast bacilli. Sputum culture yielded growth of non-fermentative Gram negative bacilli on two occasions, but blood culture was sterile. The isolate was identified as B. cepacia by Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). The patient’s general condition remained poor and in spite of initiation of antibiotics, the patient expired after an episode of massive hemoptysis.

Conclusion: This report raises concerns regarding the spread and severity of B. cepacia infection in non-compromised patients in the community and the need to suspect and identify it. Since the organism is inherently resistant to antipseudomonal penicillins, aminoglycosides and polymyxin B, differentiation from Pseudomonas spp. and determining antimicrobial susceptibility is paramount for treatment.

Keywords: Burkholderia cepacia pneumonia, non-cystic fibrosis, antipseudomonal penicillins, antimicrobial, B. cepacia, Pseudomonas spp.

Graphical Abstract

[1]
Bayram, M.; Babalık, M.; Bakan, N.D.; Döngel, I. Community-acquired Burkholderia cepacia pneumonia: a report of two immunocompetent patients. Tuberk. Toraks, 2011, 59(4), 380-383.
[http://dx.doi.org/10.5578/tt.1159] [PMID: 22233309]
[2]
Suresh, G.; Prakasha, S.R.; Giridhar, B.H.; Prakash, K.S. Cavity in the lung: a rare case of Burkholderia cepacia infection. Nitte Univ. J. Health Sci., 2013, 3(2), 100-101.
[3]
Procop, G.W.; Church, D.L.; Hall, G.S.; Janda, W.M.; Koneman, E.W.; Schreckenberger, P.C. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, 7th ed; Wolters Kluwer Health: Philadelphia, 2017.
[4]
Yonas, E.; Damay, V.; Pranata, R.; Nusarintowati, N. Infective endocarditis due to Burkholderia cepacia in a neonate: a case report. J. Med. Case Reports, 2018, 12(1), 120.
[http://dx.doi.org/10.1186/s13256-018-1633-z] [PMID: 29734941]
[5]
Tamma, P.D.; Fan, Y.; Bergman, Y.; Sick-Samuels, A.C.; Hsu, A.J.; Timp, W.; Simner, P.J.; Prokesch, B.C.; Greenberg, D.E. Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam. Antimicrob. Agents Chemother., 2018, 62(4), e02213-e02217.
[http://dx.doi.org/10.1128/AAC.02213-17] [PMID: 29588357]
[6]
Kenna, D.T.D.; Lilley, D.; Coward, A.; Martin, K.; Perry, C.; Pike, R.; Hill, R.; Turton, J.F. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients. J. Med. Microbiol., 2017, 66(4), 490-501.
[http://dx.doi.org/10.1099/jmm.0.000458] [PMID: 28463663]
[7]
Matthaiou, D.K.; Chasou, E.; Atmatzidis, S.; Tsolkas, P. A case of bacteremia due to Burkholderia cepacia in a patient without cystic fibrosis. Respir. Med. CME, 2011, 4, 144-145.
[http://dx.doi.org/10.1016/j.rmedc.2010.11.002]
[8]
Mahenthiralingam, E.; Vandamme, P. Taxonomy and pathogenesis of the Burkholderia cepacia complex. Chron. Respir. Dis., 2005, 2(4), 209-217.
[http://dx.doi.org/10.1191/1479972305cd053ra] [PMID: 16541604]
[9]
Karanth, S.S.; Regunath, H.; Chawla, K.; Prabhu, M. A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual. Asian Pac. J. Trop. Biomed., 2012, 2(2), 166-168.
[http://dx.doi.org/10.1016/S2221-1691(11)60215-3] [PMID: 23569891]
[10]
Gautam, V.; Singhal, L.; Ray, P. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter. Indian J. Med. Microbiol., 2011, 29(1), 4-12.
[http://dx.doi.org/10.4103/0255-0857.76516] [PMID: 21304187]
[11]
Hauser, N.; Orsini, J. Cepacia syndrome in a non-cystic fibrosis patient. Case Reports Infect. Dis, 2015. 4.on 22 March 2018 Article ID 537627 Available from:
[http://dx.doi.org/10.1155/2015/537627]
[12]
Ledson, M.J.; Gallagher, M.J.; Walshaw, M.J. Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax, 1998, 53(5), 430-432.
[http://dx.doi.org/10.1136/thx.53.5.430] [PMID: 9708240]
[13]
Waterer, G.W.; Jones, C.B.; Wunderink, R.G. Bacteremic community-acquired pneumonia in an immunocompetent adult due to Burkholderia cepacia. Chest, 1999, 116(6), 1842-1843.
[http://dx.doi.org/10.1378/chest.116.6.1842] [PMID: 10593827]
[14]
Belchis, D.A.; Simpson, E.; Colby, T. Histopathologic features of Burkholderia cepacia pneumonia in patients without cystic fibrosis. Mod. Pathol., 2000, 13(4), 369-372.
[http://dx.doi.org/10.1038/modpathol.3880060] [PMID: 10786801]
[15]
Pujol, M.; Corbella, X.; Carratala, J.; Gudiol, F. Community-acquired bacteremic Pseudomonas cepacia pneumonia in an immunocompetent host. Clin. Infect. Dis., 1992, 15(5), 887-888.
[http://dx.doi.org/10.1093/clind/15.5.887] [PMID: 1280168]
[16]
Mali, S.; Dash, L.; Gautam, V.; Shastri, J.; Kumar, S. An outbreak of Burkholderia cepacia complex in the paediatric unit of a tertiary care hospital. Indian J. Med. Microbiol., 2017, 35(2), 216-220.
[PMID: 28681809]
[17]
Drevinek, P.; Mahenthiralingam, E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin. Microbiol. Infect., 2010, 16(7), 821-830.
[http://dx.doi.org/10.1111/j.1469-0691.2010.03237.x] [PMID: 20880411]
[18]
Mahenthiralingam, E.; Baldwin, A.; Dowson, C.G. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J. Appl. Microbiol., 2008, 104(6), 1539-1551.
[http://dx.doi.org/10.1111/j.1365-2672.2007.03706.x] [PMID: 18217926]

Rights & Permissions Print Cite
Article Metrics
17
1
© 2024 Bentham Science Publishers | Privacy Policy